The geoepidemiology of immune thrombocytopenic purpura

First described in 1735 (Watson-Williams et al., 1958 [1]), immune-mediated platelet destruction is a phenomenon of protean associations that has historically varied in its definition. Recently, consensus guidelines were proposed for a standardized system of nomenclature that preserves the acronym “...

Full description

Saved in:
Bibliographic Details
Published inAutoimmunity reviews Vol. 9; no. 5; pp. A342 - A349
Main Authors Deane, Sean, Teuber, Suzanne S., Gershwin, M. Eric
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.03.2010
Subjects
Online AccessGet full text
ISSN1568-9972
1568-9972
1873-0183
DOI10.1016/j.autrev.2009.11.020

Cover

More Information
Summary:First described in 1735 (Watson-Williams et al., 1958 [1]), immune-mediated platelet destruction is a phenomenon of protean associations that has historically varied in its definition. Recently, consensus guidelines were proposed for a standardized system of nomenclature that preserves the acronym “ITP” but encompasses a number of causes of immune-mediated thrombocytopenias, including both primary immune thrombocytopenia as well as such entities as thrombocytopenia associated with connective tissue diseases or cancer. In this paper, we will focus on current aspects of geoepidemiology, pathophysiology, diagnosis and management of adult and pediatric primary immune thrombocytopenia. It is clear that both genetic and extrinsic factors exist for ITP and are likely different between children and adults. Immune thrombocytopenia remains a challenging problem but our understanding of its pathophysiology has greatly improved.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1568-9972
1568-9972
1873-0183
DOI:10.1016/j.autrev.2009.11.020